Your session is about to expire
← Back to Search
Non-invasive Brain Stimulation
rTMS for Depression
N/A
Recruiting
Led By Nolan Williams, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Male or Female, between the ages of 22 and 65 at the time of screening
Male or Female, between the ages of 22 and 65 at the time of screening.
Must not have
Depth-adjusted aiTBS treatment dose > 65% maximum stimulator output (MSO)
Untreated or insufficiently treated endocrine disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline (pre-intervention), during the intervention and immediately after the intervention.
Summary
This trial looks at whether a new kind of brain stimulation called "aiTBS" can help people with borderline personality disorder who also have depression.
Who is the study for?
Adults aged 22-65 with Borderline Personality Disorder and a current depressive episode, who are in good health, TMS naive, agree to lifestyle guidelines, use effective contraception if applicable, can understand English for assessments/interventions. Excludes pregnant individuals or those with mania/psychosis, substance abuse issues, certain medical conditions like metal implants incompatible with MRI or history of seizures.
What is being tested?
The trial tests an accelerated form of theta-burst stimulation (aiTBS) on the brain's left dorsolateral prefrontal cortex and dorsomedial prefrontal cortex versus sham stimulation. It aims to assess aiTBS's effectiveness in alleviating depression symptoms in participants with BPD during a depressive episode.
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site, headache, lightheadedness, temporary hearing changes due to the noise of the machine. Rarely there could be seizure risk or more severe headaches.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 22 and 65 years old.
Select...
I am between 22 and 65 years old.
Select...
I have been diagnosed with MDD, BAPD II, or unspecified depressive disorder and Borderline Personality Disorder.
Select...
I have never undergone TMS therapy.
Select...
I have never undergone TMS therapy.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My treatment's intensity is more than 65% of the maximum level.
Select...
I have a hormone disorder that hasn't been treated enough.
Select...
I have used ketamine or had ECT for depression recently.
Select...
I am currently experiencing mania or psychosis.
Select...
I have a history of serious brain or nerve conditions.
Select...
I've had more than 8 ECT sessions without improvement.
Select...
I have been diagnosed with obsessive-compulsive disorder.
Select...
I do not have metal implants in my head, a history of seizures, or known brain lesions.
Select...
I have been diagnosed with Bipolar I Disorder or a primary psychotic disorder.
Select...
I sleep at least 5 hours each night.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline (pre-intervention), during the intervention and immediately after the intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline (pre-intervention), during the intervention and immediately after the intervention.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mental Depression
Secondary study objectives
Change in the clinician rated Montgomery-Asberg Depression Rating Scale (MADRS-C) in active DMPFC vs. sham aiTBS.
Feasibility of aiTBS in individuals with BPD and comorbid MDD or BAD II in a current MDE as defined by recruitment rate
Feasibility of aiTBS in individuals with BPD and comorbid MDD or BAD II in a current MDE as defined by retention rates
+1 moreTrial Design
3Treatment groups
Active Control
Placebo Group
Group I: Left Dorsolateral Prefrontal Cortex (L-DLPFC)Active Control1 Intervention
The accelerated theta burst stimulation protocol will be applied to the left dorsolateral prefrontal cortex (L-DLPFC)
Group II: Dorsomedial Prefrontal Cortex (DMPFC)Active Control1 Intervention
The accelerated theta burst stimulation protocol will be applied to the dorsomedial prefrontal cortex (DMPFC)
Group III: Sham stimulationPlacebo Group1 Intervention
Sham (non-active) stimulation will be applied to the left dorsolateral prefrontal cortex (DLPFC) region
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,474 Previous Clinical Trials
17,501,895 Total Patients Enrolled
2 Trials studying Borderline Personality Disorder
63 Patients Enrolled for Borderline Personality Disorder
Nolan Williams, MDPrincipal InvestigatorStanford University
17 Previous Clinical Trials
1,237 Total Patients Enrolled
David Spiegel, MDPrincipal InvestigatorStanford University
11 Previous Clinical Trials
1,772 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My treatment's intensity is more than 65% of the maximum level.I am between 22 and 65 years old.I have a hormone disorder that hasn't been treated enough.I have used ketamine or had ECT for depression recently.I am currently experiencing mania or psychosis.I have access to psychiatric care before and after the study.I have been diagnosed with depression and borderline personality disorder.I can get rTMS treatment after the study ends.You have been diagnosed with autism or a developmental disability that affects your thinking and learning abilities.I have access to psychiatric care before and after the study.I am between 22 and 65 years old.I have been diagnosed with MDD, BAPD II, or unspecified depressive disorder and Borderline Personality Disorder.I have a history of serious brain or nerve conditions.I've had more than 8 ECT sessions without improvement.I have been diagnosed with obsessive-compulsive disorder.I have never undergone TMS therapy.I can get rTMS treatment after the study ends.I do not have metal implants in my head, a history of seizures, or known brain lesions.You agree to follow certain lifestyle guidelines for the entire study period.You currently have a serious problem with drugs or alcohol, or are experiencing withdrawal symptoms.I have never undergone TMS therapy.I have been diagnosed with Bipolar I Disorder or a primary psychotic disorder.You have been diagnosed with significant anxiety disorder, personality disorder, or long-lasting sadness (dysthymia).I sleep at least 5 hours each night.
Research Study Groups:
This trial has the following groups:- Group 1: Left Dorsolateral Prefrontal Cortex (L-DLPFC)
- Group 2: Dorsomedial Prefrontal Cortex (DMPFC)
- Group 3: Sham stimulation
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Borderline Personality Disorder Patient Testimony for trial: Trial Name: NCT04870255 — N/A
Share this study with friends
Copy Link
Messenger